Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
Clinical trial NCT02092207 · COMPLETED
Trial details
- NCT number
- NCT02092207
- Sponsor
- Yungjin Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-06-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.